Page last updated: 2024-08-24

gemcitabine and Burns

gemcitabine has been researched along with Burns in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Giacalone, N; Haar, L; James, L; Noel, G; Ogle, C; Osterburg, A; Schwemberger, S; Thomas, I; Wang, Q	1

Other Studies

1 other study(ies) available for gemcitabine and Burns

Article	Year
A ribonucleotide reductase inhibitor reverses burn-induced inflammatory defects. Shock (Augusta, Ga.), 2010, Volume: 34, Issue:5 Topics: Animals; Burns; Concanavalin A; Deoxycytidine; Drug Evaluation, Preclinical; Gemcitabine; Interleukin-10; Interleukin-6; Leukocyte Count; Lipopolysaccharides; Lymphocyte Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes; Myeloid Cells; Nitric Oxide; Peptidoglycan; Pseudomonas Infections; Ribonucleotide Reductases; Spleen; T-Lymphocyte Subsets; Tumor Necrosis Factor-alpha	2010

Article

Year

A ribonucleotide reductase inhibitor reverses burn-induced inflammatory defects.

Shock (Augusta, Ga.), 2010, Volume: 34, Issue:5

Topics: Animals; Burns; Concanavalin A; Deoxycytidine; Drug Evaluation, Preclinical; Gemcitabine; Interleukin-10; Interleukin-6; Leukocyte Count; Lipopolysaccharides; Lymphocyte Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes; Myeloid Cells; Nitric Oxide; Peptidoglycan; Pseudomonas Infections; Ribonucleotide Reductases; Spleen; T-Lymphocyte Subsets; Tumor Necrosis Factor-alpha

2010